Alexandre Fugere
Overview
Explore the profile of Alexandre Fugere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maranda B, Labbe S, Lurquin M, Brabant P, Fugere A, Larrivee J, et al.
Lancet Infect Dis
. 2023 Aug;
24(1):25-35.
PMID: 37619584
Background: COVID-19 severity is associated with its respiratory manifestations. Neutralising antibodies against SARS-CoV-2 administered systemically have shown clinical efficacy. However, immediate and direct delivery of neutralising antibodies via inhalation might...
2.
Ster C, Lebeau V, Leclerc J, Fugere A, Veh K, Roy J, et al.
Vet Res
. 2017 Sep;
48(1):56.
PMID: 28934980
Staphylococcus aureus intramammary infections (IMIs) have low cure rates using standard antibiotic treatment and increasing the duration of treatment usually improves therapeutic success. Chronic IMIs are thought to be caused...
3.
Fugere A, Seguin D, Mitchell G, Deziel E, Dekimpe V, Cantin A, et al.
PLoS One
. 2014 Jan;
9(1):e86705.
PMID: 24466207
Pseudomonas aeruginosa and Staphylococcus aureus are the most prevalent pathogens in airway infections of cystic fibrosis (CF) patients. We studied how these pathogens coexist and interact with each other. Clinical...
4.
Mitchell G, Fugere A, Pepin Gaudreau K, Brouillette E, Frost E, Cantin A, et al.
PLoS One
. 2013 May;
8(5):e65018.
PMID: 23705029
Staphylococcus aureus small-colony variants (SCVs) are persistent pathogenic bacteria characterized by slow growth and, for many of these strains, an increased ability to form biofilms and to persist within host...